Skip to main content
Log in

Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-κB control

  • Short Report
  • Published:
Oncogene Submit manuscript

Abstract

RelB is an unusual member of the Rel/NF-κB family of transcription factors which are involved in oncogenic processes. Due to a relaxed control by the IκBs, the cytosolic NF-κB inhibitors, RelB is constitutively expressed in the nuclei of lymphoid cells. We show here that RelB is inducibly degraded upon activation of T cells in a fashion similar to the IκBs. However, RelB degradation differs from that of IκBs since it is not induced by TNFα but only by T cell receptor or TPA/ionomycin stimulation. Moreover, RelB degradation occurs in three steps: (i) after stimulation RelB is rapidly phosphorylated at amino acids Thr84 and Ser552 followed by (ii) an N-terminal cut and, finally, (iii) the complete degradation in the proteasomes. Since mutation of the two phosphoacceptor sites to non-acceptor sites abolished RelB phosphorylation in vivo and led to the stabilization of the mutated RelBDM, site-specific phosphorylation appears to be a necessary prerequisite for RelB degradation. RelB is a crucial regulator of NF-κB-dependent gene expression. Thus, the signal-induced degradation of RelB should be an important control mechanism of NF-κB activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 3
Figure 2
Figure 4

Similar content being viewed by others

References

  • Baldwin Jr AS . 1996 Annu. Rev. Immunol. 14: 649–683

  • Barton D, HogenEsch H, Weih F . 2000 Eur. J. Immunol. 30: 2323–2332

  • Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U . 1995 Science 267: 1485–1488

  • Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Cate R, Lo D . 1995 Nature 373: 531–536

  • Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T . 1995 Genes Dev. 9: 1586–1597

  • DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, Ghosh S, Karin M . 1996 Mol. Cell. Biol. 16: 1295–1304

  • Dobrzanski P, Ryseck RP, Bravo R . 1993 Mol. Cell. Biol. 13: 1572–1582

  • Dobrzanski P, Ryseck RP, Bravo R . 1994 EMBO J. 13: 4608–4616

  • Ghosh S, May MJ, Kopp EB . 1998 Annu. Rev. Immunol. 16: 225–260

  • Gilmore TD, Koedood M, Piffat KA, White DW . 1996 Oncogene 13: 1367–1378

  • Hibi M, Lin A, Smeal T, Minden A, Karin M . 1993 Genes Dev. 7: 2135–2148

  • Karin M, Ben-Neriah Y . 2000 Annu. Rev. Immunol. 18: 621–663

  • Lernbecher T, Muller U, Wirth T . 1993 Nature 365: 767–770

  • Marienfeld R, Neumann M, Chuvpilo S, Escher C, Kneitz B, Avots A, Schimpl A, Serfling E . 1997 Eur. J. Immunol. 27: 1601–1609

  • Neumann M, Grieshammer T, Chuvpilo S, Kneitz B, Lohoff M, Schimpl A, Franza Jr BR, Serfling E . 1995 EMBO J. 14: 1991–2004

  • Neumann M, Marienfeld R, Serfling E . 1997 Int. J. Oncol. 11: 1335–1347

  • Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M . 1997 Cell 90: 373–383

  • Ryseck RP, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R . 1992 Mol. Cell. Biol. 12: 674–684

  • Suhasini M, Reddy CD, Reddy EP, DiDonato JA, Pilz RB . 1997 Oncogene 15: 1859–1870

  • Tojima Y, Fujimoto A, Delhase M, Chen Y, Hatakeyama S, Nakayama K, Kaneko Y, Nimura Y, Motoyama N, Ikeda K, Karin M, Nakanishi M . 2000 Nature 404: 778–782

  • Weih F, Carrasco D, Bravo R . 1994 Oncogene 9: 3289–3297

  • Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA, Bravo R . 1995 Cell 80: 331–340

  • Xia Y, Chen S, Wang Y, Mackman N, Ku G, Lo D, Feng L . 1999 Mol. Cell. Biol. 19: 7688–7696

Download references

Acknowledgements

We thank I Pietrowski and H Wecklein for excellent technical assistance. For critical reading of the manuscript we are indebted to Drs A Avots, S Klein-Hessling, A Schimpl, A Wilisch-Neumann and T Wirth. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (NE 608/1-3 and 608/2-2 to M Neumann) and the Wilhelm-Sander Stiftung.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manfred Neumann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marienfeld, R., Berberich-Siebelt, F., Berberich, I. et al. Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-κB control. Oncogene 20, 8142–8147 (2001). https://doi.org/10.1038/sj.onc.1204884

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204884

  • Springer Nature Limited

Keywords

This article is cited by

Navigation